Patient safety is a significant issue for gastrointestinal endoscopists. Infection spread by Carbapenem-resistant Enterobacteriaceae (CRE) through a procedure called ERCP (endoscopic retrograde cholangiopancreatography) was recently mentioned in the news. ECRP is an advanced endoscopic procedure that most people will never need to have. However, for those who do require it, ERCP is a critical procedure that can be potentially life-saving.
A 12-week IBM wellness program paid more than 11,000 employees with children a $150 cash rebate for improving family eating and exercise habits, according to a report in Pediatrics. Eating healthier was the most common family goal, and those who completed the program said their families did more physical activity together, ate more nutritious meals, and spent less time in front of a computer or TV screen.
A Phase III study found that Santarus and Cosmo Pharmaceuticals' budesonide MMX worked better than a dummy pill at putting patients with mild or moderate active ulcerative colitis in remission after eight weeks. Both 9- and 6-milligram doses of the treatment were well tolerated, the drugmakers said.
A study in the journal Obesity said people who joined the nonprofit group called Take Off Pounds Sensibly, or TOPS, lost an average of 5.9% to 7.1% of their body weight and kept it off for two years. Researchers said the results are similar to weight loss from other programs, such as Weight Watchers and the Atkins diet.
Adolescents with chronic pancreatitis have less pain long-term following endoscopic retrograde cholangiopancreatography, study data showed. Researchers reviewed 42 cases and found five children required surgery for ERCP-resistant pain, but 81.1% of the remaining children had improvements in pain, including almost 65% with complete pain relief.